CurrentUnitedHealthcarePolicy CS097.R

Pneumatic Compression Devices

UnitedHealthcare medical policy CS097.R on pneumatic compression devices (PCDs) covering indications, evidence review, and applicability; excludes specified states where separate state-specific policies apply. Discusses medical necessity determinations for use in lymphedema, chronic venous insufficiency with ulcers, peripheral arterial disease, prevention of DVT, and head/neck lymphedema.

Policy Summary

PayerUnitedHealthcare

PolicyPneumatic Compression Devices

Policy CodePolicy CS097.R

Change TypeRevised coverage language; evidence update

Effective DateJuly 1, 2025

Next Review Date

Key ActionProviders must document that members meet the InterQual CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices clinical coverage criteria for medical necessity determinations for PCDs.

POLICY UPDATE CHANGES

Replaced language indicating IPC devices are proven and medically necessary in an outpatient setting or upon discharge with language stating IPC devices are proven and medically necessary in certain circumstances for prevention of DVT.

Added language clarifying that benefit coverage is determined by federal, state, or contractual requirements and that medical records may be required for coverage assessment.

Updated Clinical Evidence and References sections to reflect most current information.

3Major coverage positions (proven vs unproven vs conditional)

11Document pages in Part 1

3.6%

Stroke trial DVT risk reduction (CLOTS3)

3.1% vs 1.4%CLOTS3 skin breaks (IPC vs no IPC)

21% vs 37%Achilles repair trial 2-week DVT

Coverage Summary

This policy (CS097.R, effective July 1, 2025) takes a mixed coverage stance: pneumatic compression devices (PCDs) and intermittent pneumatic compression (IPC) are considered proven and medically necessary in certain circumstances — specifically for treatment of lymphedema or chronic venous insufficiency (CVI) with edema and non-healing lower extremity ulcers when InterQual clinical criteria are met, and for prevention of deep venous thrombosis (DVT) when InterQual criteria for mechanical prophylaxis are met. Conversely, advanced pneumatic compression devices (APCDs) for head/face/neck lymphedema and high-pressure, rapid inflation/deflation PCDs for peripheral arterial disease (PAD) are considered unproven and not medically necessary.

Policy metadata

policy_numberCS097.R

effective_dateJuly 1, 2025

statusCURRENT

scope_summaryUnitedHealthcare medical policy on pneumatic compression devices covering indications, evidence review, and applicability; addresses lymphedema, CVI with non-healing ulcers, PAD, DVT prevention, and head/neck lymphedema; excludes listed states with state-specific policies.

High-level coverage positions

ALL of the following

Advanced intermittent pneumatic compression devices (e.g., Flexitouch) for treating lymphedema of the head, face, or neck are considered unproven and not medically necessary.
explicit negative coverage statement
Pneumatic compression devices (high pressure, rapid inflation/deflation cycle) for treating peripheral arterial disease (PAD) are considered unproven and not medically necessary.
explicit negative coverage statement
Pneumatic compression devices are proven and medically necessary in certain circumstances for the treatment of lymphedema or chronic venous insufficiency (CVI) with edema and non-healing lower extremity ulcers when criteria in InterQual CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices are met.
covers use contingent on meeting InterQual criteria
Intermittent limb compression devices are proven and medically necessary in certain circumstances for prevention of deep venous thrombosis (DVT) when medical necessity clinical coverage criteria in InterQual CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices are met.

Medical Necessity Criteria

Coverage Rationale (summary of change)

Policy language was revised to restrict prior broader outpatient coverage; InterQual CP determines specific clinical criteria (see InterQual CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices).

Intermittent limb compression devices are considered proven and medically necessary in certain circumstances for the prevention of deep venous thrombosis (DVT).

Specific clinical criteria and contexts (e.g., inpatient immobile stroke patients, postoperative immobilized patients with contraindication to pharmacologic prophylaxis) referenced in the body of the policy determine coverage.

Clinical Evidence & Guidelines Summary

Clinical guideline-supported indications and contra-indications (evidence summary)

Guidelines provide conditional recommendations for mechanical prophylaxis; contraindications where mechanical prophylaxis should not be used are listed.

Guideline recommendations supporting IPC or mechanical prophylaxis

ASH 2019/2018/2022: For patients at high risk for bleeding, mechanical methods may be favored over pharmacologic prophylaxis; for patients who do not receive pharmacologic prophylaxis, use mechanical prophylaxis over no mechanical prophylaxis; prefer intermittent compression devices over graduated compression stockings; consider combined mechanical and pharmacological prophylaxis for patients receiving pharmacologic prophylaxis, especially those at high VTE risk.
European 2024: Recommend an institution-wide VTE protocol integrating early ambulation, pharmacologic thromboprophylaxis and mechanical thromboprophylaxis; suggest IPC for hospitalized patients with high VTE risk and high bleeding risk and note IPC may be more effective than GCS in some contexts.

Coding

No codes listed in Part 1mixed

No codes listed

FDA product codes and device classification (informational)mixed

JOW	FDA product code for pneumatic compression devices (Class II)

For device identification and review, note that pneumatic compression systems are regulated as FDA Class II devices. The Flexitouch Plus System received FDA clearance on December 20, 2020. Reviewers should use FDA/product code information (product code JOW) and FDA clearance references when verifying specific devices during medical necessity review.

Provider Actions & Billing Impact

Documentation Required

Follow InterQual clinical criteria

Providers must refer to and document that members meet the InterQual CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices clinical coverage criteria when making medical necessity determinations for PCDs used to treat lymphedema, chronic venous insufficiency with non-healing lower extremity ulcers, and for DVT prophylaxis.

Denial Risk

Head/neck lymphedema APCD denials likely

Claims for advanced intermittent pneumatic compression devices (APCDs) used to treat lymphedema of the head, face, or neck are considered unproven and not medically necessary and are subject to denial.

Definitions

Term	Definition
APCD	Advanced pneumatic compression device (examples include Flexitouch) designed for complex garments and programmable regimens, including head/neck applications.
IPC	Intermittent pneumatic compression - inflatable sleeves applied to limbs that inflate/deflate to reduce stasis and venous thromboembolism (VTE) risk.
PCD	Pneumatic compression device - general term covering IPC and advanced devices that use an air compressor and garments to sequentially inflate and deflate to treat edema, lymphedema, chronic wounds, and reduce venous stasis.
GCS	Graduated compression stockings.

Revision History

07/01/2025material_changeLatest

Clarified restriction of prior broader outpatient coverage: policy language replaced statement that IPC devices are proven and medically necessary in an outpatient setting or upon discharge with language stating IPC devices are proven and medically necessary in certain circumstances for prevention of DVT; archived previous policy version CS097.Q.

07/01/2025non_material_change

Added pointer to guidelines titled 'Medical Records Documentation Used for Reviews' and added language that benefit coverage is determined by federal, state, or contractual requirements and that medical records documentation may be required to assess whether the member meets clinical criteria for coverage.

07/01/2025

Policy Summary

PayerUnitedHealthcare

PolicyPneumatic Compression Devices

Policy CodePolicy CS097.R

Change TypeRevised coverage language; evidence update

Effective DateJuly 1, 2025

Next Review Date

On This Page

covers prophylactic IPC per InterQual criteria

AAPS 2016: Recommend using IPC to prevent perioperative VTE in plastic surgery patients; IPC superior to elastic compression stockings.

Contraindications where mechanical prophylaxis should not be used (NICE)

Suspected or proven peripheral arterial disease
Peripheral arterial bypass grafting
Peripheral neuropathy or other causes of sensory impairment
Any local conditions in which mechanical prophylaxis may cause damage (e.g., fragile skin, dermatitis, gangrene, recent skin graft)
Severe leg edema
Major limb deformity or unusual leg size or shape that prevents a correct fit

Clinical trial evidence excerpts (selected)

Randomized trial evidence demonstrating effectiveness in specific populations.

ANY of the following

CLOTS 3 (stroke): In immobile stroke patients, IPC versus no IPC reduced DVT from 12.1% to 8.5% (absolute risk reduction 3.6%; RR 0.69); adjusted OR 0.65; improved 6-month survival (HR 0.86) but no disability improvement; harms included increased skin breaks and falls with injury.
Domeij-Arverud et al. (Achilles repair): In postoperative immobilized outpatients after Achilles tendon repair, IPC 6 hours/day for 2 weeks reduced DVT at 2 weeks (21% vs 37%; p=0.042); the effect was not seen at 6 weeks after IPC was discontinued.

Pneumatic compression devices (PCDs) include traditional single- or multi-chambered systems that attach to garments and sequentially inflate and deflate to apply pressure to reduce edema and venous stasis. Intermittent pneumatic compression (IPC) refers to inflatable sleeves applied to the calf and/or thigh that inflate sequentially to increase venous flow and reduce DVT risk. Devices range from simple IPC sleeves to more complex advanced pneumatic compression devices (APCDs) offering multiple garment options, programmable regimens, and specialized head/neck garments used for fibrosis, edema, chronic wounds, and localized swelling.

Evidence summaries

DVT prevention evidence summaryMultiple RCTs, systematic reviews and meta-analyses show IPC can reduce DVT in immobile stroke and some surgical populations (CLOTS3: absolute risk reduction 3.6%, adjusted OR 0.65) and combined IPC+pharmacologic prophylaxis reduces PE and DVT vs pharmacologic alone; evidence heterogeneous across settings.

CLOTS3 primary outcomeIPC 8.5% vs no IPC 12.1%; absolute reduction 3.6%; RR 0.69; adjusted OR 0.65; improved 6-month survival (HR 0.86).

Domeij-Arverud 2-week DVTAfter Achilles tendon repair, IPC 6 hrs/day for 2 weeks reduced DVT at 2 weeks: 21% vs 37% (p=0.042); effect not maintained at 6 weeks after IPC stopped.

CVI/venous ulcer evidence summaryRCT evidence suggests adjunctive IPC plus standard compression improved median time to wound closure (141 vs 211 days; p=0.031) and increased healing rate and reduced pain versus compression alone.

Lymphedema head/neck evidence summarySystematic reviews and small RCTs/observational studies show limited, low-quality evidence for APCDs in head/neck lymphedema; some trials report short-term symptom or external swelling improvement but overall evidence insufficient to establish efficacy.

PAD evidence summarySystematic reviews and small RCTs show inconsistent, low-quality evidence; some trials report improved walking distance, pain or ulcer healing in CLI, but overall evidence insufficient to determine safety/efficacy of high-pressure PCDs for PAD.

Cochrane (combined IPC + pharmacologic)Cochrane review found combined IPC and pharmacologic prophylaxis reduced PE (OR 0.46) and DVT versus pharmacologic alone (low to high certainty depending on outcome).

Denial Risk

PAD high-pressure PCD denials likely

Claims for high-pressure, rapid inflation/deflation cycle pneumatic compression devices for the treatment of peripheral arterial disease (PAD) are considered unproven and not medically necessary and are subject to denial.

Documentation Required

Medical records may be required for coverage review

Medical records and clinical documentation may be requested to assess whether the member meets the applicable clinical criteria for coverage. Submission of records does not guarantee coverage; federal, state, or contractual benefit requirements and applicable laws govern final coverage determinations.

Billing Rule

FDA clearance information for device identification

Use FDA clearance and product code references when verifying device identity during coverage and billing review. Devices and systems to perform pneumatic compression are regulated as FDA Class II (product code JOW). Example: the Flexitouch Plus System received FDA clearance on December 20, 2020.

Supporting evidence and references updated: Clinical Evidence and References sections revised to reflect the most current information.